Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SP and DP for Malaria Prevention in Pregnancy (Uganda)
NCT04336189Phase 3Completed
- Start
- Dec 2020
- Primary completion
- Jul 2024
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of sulfadoxine + pyrimethamine, dihydroartemisinin + piperaquine in malaria. Started Dec 2020; status: completed.
02
Drugs
sulfadoxine + pyrimethaminedihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT04336189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04336189.